These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

356 related articles for article (PubMed ID: 31755376)

  • 1. Pleural mesothelioma and lung cancer: the role of asbestos exposure and genetic variants in selected iron metabolism and inflammation genes.
    Celsi F; Crovella S; Moura RR; Schneider M; Vita F; Finotto L; Zabucchi G; Zacchi P; Borelli V
    J Toxicol Environ Health A; 2019; 82(20):1088-1102. PubMed ID: 31755376
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Iron signature in asbestos-induced malignant pleural mesothelioma: A population-based autopsy study.
    Crovella S; Bianco AM; Vuch J; Zupin L; Moura RR; Trevisan E; Schneider M; Brollo A; Nicastro EM; Cosenzi A; Zabucchi G; Borelli V
    J Toxicol Environ Health A; 2016; 79(3):129-41. PubMed ID: 26818092
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased Standardised Incidence Ratio of Malignant Pleural Mesothelioma in Taiwanese Asbestos Workers: A 29-Year Retrospective Cohort Study.
    Lin CK; Chang YY; Wang JD; Lee LJ
    Biomed Res Int; 2015; 2015():678598. PubMed ID: 26290869
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Upcoming epidemic of asbestos-related malignant pleural mesothelioma in Taiwan: A prediction of incidence in the next 30 years.
    Lin RT; Chang YY; Wang JD; Lee LJ
    J Formos Med Assoc; 2019 Jan; 118(1 Pt 3):463-470. PubMed ID: 30072200
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gene-asbestos interaction in malignant pleural mesothelioma susceptibility.
    Tunesi S; Ferrante D; Mirabelli D; Andorno S; Betti M; Fiorito G; Guarrera S; Casalone E; Neri M; Ugolini D; Bonassi S; Matullo G; Dianzani I; Magnani C
    Carcinogenesis; 2015 Oct; 36(10):1129-35. PubMed ID: 26139392
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A genetic variant of NLRP1 gene is associated with asbestos body burden in patients with malignant pleural mesothelioma.
    Crovella S; Moura RR; Cappellani S; Celsi F; Trevisan E; Schneider M; Brollo A; Nicastro EM; Vita F; Finotto L; Zabucchi G; Borelli V
    J Toxicol Environ Health A; 2018; 81(5):98-105. PubMed ID: 29265930
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Physician requests by patients with malignant pleural mesothelioma in Japan.
    Nagamatsu Y; Oze I; Aoe K; Hotta K; Kato K; Nakagawa J; Hara K; Kishimoto T; Fujimoto N
    BMC Cancer; 2019 Apr; 19(1):383. PubMed ID: 31023248
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Increased risk of mesothelioma and lung cancer among workers exposed to asbestos who could require an anticipated retirement].
    Merler E; Girardi P; Panato C; Bressan V
    Epidemiol Prev; 2016; 40(1 Suppl 1):26-34. PubMed ID: 26951730
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Malignant pleural mesothelioma incidence and survival in the Republic of Ireland 1994-2009.
    Jennings CJ; Walsh PM; Deady S; Harvey BJ; Thomas W
    Cancer Epidemiol; 2014 Feb; 38(1):35-41. PubMed ID: 24394956
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential mutation profiles and similar intronic TP53 polymorphisms in asbestos-related lung cancer and pleural mesothelioma.
    Andujar P; Pairon JC; Renier A; Descatha A; Hysi I; Abd-Alsamad I; Billon-Galland MA; Blons H; Clin B; Danel C; Debrosse D; Galateau-Sallé F; Housset B; Laurent-Puig P; Le Pimpec-Barthes F; Letourneux M; Monnet I; Régnard JF; Validire P; Zucman-Rossi J; Jaurand MC; Jean D
    Mutagenesis; 2013 May; 28(3):323-31. PubMed ID: 23435014
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Germline mutations in DNA repair genes predispose asbestos-exposed patients to malignant pleural mesothelioma.
    Betti M; Casalone E; Ferrante D; Aspesi A; Morleo G; Biasi A; Sculco M; Mancuso G; Guarrera S; Righi L; Grosso F; Libener R; Pavesi M; Mariani N; Casadio C; Boldorini R; Mirabelli D; Pasini B; Magnani C; Matullo G; Dianzani I
    Cancer Lett; 2017 Oct; 405():38-45. PubMed ID: 28687356
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical and prognostic features of erionite-induced malignant mesothelioma.
    Demirer E; Ghattas CF; Radwan MO; Elamin EM
    Yonsei Med J; 2015 Mar; 56(2):311-23. PubMed ID: 25683976
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chemokines involved in the early inflammatory response and in pro-tumoral activity in asbestos-exposed workers from an Italian coastal area with territorial clusters of pleural malignant mesothelioma.
    Comar M; Zanotta N; Zanconati F; Cortale M; Bonotti A; Cristaudo A; Bovenzi M
    Lung Cancer; 2016 Apr; 94():61-7. PubMed ID: 26973208
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pleural mesothelioma in household members of asbestos-exposed workers in Friuli Venezia Giulia, Italy.
    D' Agostin F; de Michieli P; Negro C
    Int J Occup Med Environ Health; 2017 May; 30(3):419-431. PubMed ID: 28481375
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CDKN2A copy number and p16 expression in malignant pleural mesothelioma in relation to asbestos exposure.
    Kettunen E; Savukoski S; Salmenkivi K; Böhling T; Vanhala E; Kuosma E; Anttila S; Wolff H
    BMC Cancer; 2019 May; 19(1):507. PubMed ID: 31138176
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genetic variants associated with increased risk of malignant pleural mesothelioma: a genome-wide association study.
    Matullo G; Guarrera S; Betti M; Fiorito G; Ferrante D; Voglino F; Cadby G; Di Gaetano C; Rosa F; Russo A; Hirvonen A; Casalone E; Tunesi S; Padoan M; Giordano M; Aspesi A; Casadio C; Ardissone F; Ruffini E; Betta PG; Libener R; Guaschino R; Piccolini E; Neri M; Musk AW; de Klerk NH; Hui J; Beilby J; James AL; Creaney J; Robinson BW; Mukherjee S; Palmer LJ; Mirabelli D; Ugolini D; Bonassi S; Magnani C; Dianzani I
    PLoS One; 2013; 8(4):e61253. PubMed ID: 23626673
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Occupational and non-occupational attributable risk of asbestos exposure for malignant pleural mesothelioma.
    Lacourt A; Gramond C; Rolland P; Ducamp S; Audignon S; Astoul P; Chamming's S; Gilg Soit Ilg A; Rinaldo M; Raherison C; Galateau-Salle F; Imbernon E; Pairon JC; Goldberg M; Brochard P
    Thorax; 2014 Jun; 69(6):532-9. PubMed ID: 24508707
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clustering of malignant pleural mesothelioma in asbestos factories: a subgroup analysis in a 29-year follow-up study to identify high-risk industries in Taiwan.
    Lee LJ; Lin CK; Pan CH; Cheng Y; Chang YY; Liou SH; Wang JD
    BMJ Open; 2018 Dec; 8(12):e021063. PubMed ID: 30530573
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Five years update on relationships between malignant pleural mesothelioma and exposure to asbestos and other elongated mineral particles.
    Andujar P; Lacourt A; Brochard P; Pairon JC; Jaurand MC; Jean D
    J Toxicol Environ Health B Crit Rev; 2016; 19(5-6):151-172. PubMed ID: 27705546
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of single nucleotide polymorphisms related to iron homeostasis in mesothelioma susceptibility after asbestos exposure: a genetic study on autoptic samples.
    Grignani P; Visonà SD; Fronda MV; Borrelli P; Monti MC; Bertoglio B; Conti A; Fattorini P; Previderè C
    Front Public Health; 2023; 11():1236558. PubMed ID: 37942251
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.